Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy.

MLA

Bütof, Rebecca, et al. “Sites of Recurrent Disease and Prognostic Factors in SCLC Patients Treated with Radiochemotherapy.” Clinical and Translational Radiation Oncology, vol. 7, Nov. 2017, pp. 36–42. EBSCOhost, https://doi.org/10.1016/j.ctro.2017.09.010.

APA

Bütof, R., Gumina, C., Valentini, C., Sommerer, A., Appold, S., Zips, D., Löck, S., Baumann, M., & Troost, E. G. C. (2017). Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy. Clinical and Translational Radiation Oncology, 7, 36–42. https://doi.org/10.1016/j.ctro.2017.09.010

Chicago

Bütof, Rebecca, Calogero Gumina, Chiara Valentini, Antje Sommerer, Steffen Appold, Daniel Zips, Steffen Löck, Michael Baumann, and Esther G C Troost. 2017. “Sites of Recurrent Disease and Prognostic Factors in SCLC Patients Treated with Radiochemotherapy.” Clinical and Translational Radiation Oncology 7 (November): 36–42. doi:10.1016/j.ctro.2017.09.010.